drugset / Trial / NCT03008850

Shivering Prevention During Cesarean Section by Intrathecal Injection of Magnesium Sulfate

NCT03008850

Phase 2/3 Completed 84 enrolled Assiut University
RandomizedParallel-groupDouble-blindPrevention

Summary

Shivering is a common post-anesthetic complication occurring in up to 65% of patients undergoing spinal or epidural anesthesia. Shivering may interfere with electrocardiogram, blood pressure and oxygen saturation monitoring. In addition, shivering increases oxygen consumption, carbon dioxide production and metabolic rate by up to 400%. Thus, it may result in problems in patients with low cardiac and pulmonary reserves. Preventing shivering could therefore result in better postoperative outcomes or reduce the incidence of post-surgical complications.

Timeline

Start
2015-06
Primary completion
2016-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Magnesium Sulfate Other / unclassified 25 mg Intrathecal

Indications

No indication recorded.